EnteroMedics Inc (NASDAQ:ETRM) reported ($0.10) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.10). During the same quarter last year, the company posted ($0.14) earnings per share. Analysts expect that EnteroMedics will post $-0.38 EPS for the current fiscal year. EnteroMedics Inc (NASDAQ:ETRM) n weekly performance is -17.39%. On last trading day company shares ended up $1.52. Analysts mean target price for the company is $4.80. EnteroMedics Inc (NASDAQ:ETRM) distance from 50-day simple moving average (SMA50) is -15.56%.
Karyopharm Therapeutics Inc (NASDAQ:KPTI) said it has entered into a Preferred Provider agreement with Veristat. Karyopharm Therapeutics Inc (NASDAQ:KPTI) shares fell -12.52% in last trading session and ended the day on $41.22. KPTI return on assets is -49.90%. Karyopharm Therapeutics Inc (NASDAQ:KPTI) quarterly performance is 2.00%.
On 13 JUNE Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB) said that The U.S. Food and Drug Administration approved Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) ‘s imaging agent, Lymphoseek, to help physicians determine the extent of head and neck cancer. Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB) shares moved down -5.17% in last trading session and was closed at $1.65, while trading in range of $1.61 – $1.71. Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB) year to date (YTD) performance is -20.29%.
Uroplasty, Inc. (NASDAQ:UPI) announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24. Uroplasty, Inc. (NASDAQ:UPI) ended the last trading day at $2.79. Company weekly volatility is calculated as 6.53% and price to cash ratio as 4.83. Uroplasty, Inc. (NASDAQ:UPI) showed a negative weekly performance of -5.74%.
On 9 JUNE Hansen Medical, Inc. (NASDAQ:HNSN) said it will showcase its new Sensei(R) X2 Robotic System prototype at Cardiostim Congress from June 18 – 21 at the Acropolis Convention Center in Nice, France. The Sensei X2 features faster image processing and a slimmer design with the stability and reachability of its predecessor. Hansen Medical, Inc. (NASDAQ:HNSN) weekly performance is -6.43%. On last trading day company shares ended up $1.31. Analysts mean target price for the company is $1.88. Hansen Medical, Inc. (NASDAQ:HNSN) distance from 50-day simple moving average (SMA50) is -26.91%.